Perhaps the most widely used targeted sequencing method is exome sequencing. The exome (the protein-coding region of the human genome) represents less than 2% of the genome, but contains ~85% of known disease-related variants,1 making whole-exome sequencing a cost-effective alternative to whole-genome sequencing.
Exome sequencing using exome enrichment can efficiently identify coding variants across a wide range of applications, including population genetics, genetic disease, and cancer studies.
Exome sequencing is a cost-effective approach when whole-genome sequencing is not practical or necessary. Sequencing only the coding regions of the genome enables researchers to focus their resources on the genes most likely to affect phenotype, and offers an accessible combination of turnaround time and price.
Exome sequencing detects variants in coding exons, with the capability to expand targeted content to include untranslated regions (UTRs) and microRNA for a more comprehensive view of gene regulation. DNA libraries can be prepared in as little as 1 day and require only 4–5 Gb of sequencing per exome.
A fast, integrated workflow for a wide range of applications providing targeted resequencing for whole-exome enrichment.
Scalable throughput and flexibility for virtually any genome, sequencing method, and scale of project.
Illumina sequencing by synthesis (SBS) chemistry is the most widely adopted next-generation sequencing (NGS) technology, generating approximately 90% of global sequencing data.*
Illumina offers integrated exome sequencing workflows like whole exome enrichment that simplify the entire process, from library preparation to data analysis and biological interpretation.
Click on the below to view products for each workflow step.
Nextera Flex for Enrichment uses a fast, user-friendly workflow. On-bead tagmentation chemistry is combined with a simplified, single hybridization protocol to reduce total workflow time.TruSeq DNA Exome
Cost-effective library preparation and exome enrichment solution that delivers exceptional target coverage over a broad range of read depths.Nextera DNA Exome
Fast library preparation and exome enrichment that accommodates low input amounts.
Targeted research panel for sequencing the protein-coding regions of the genome.TruSight One Sequencing Panels
Comprehensive panels targeting disease-associated regions of the exome with high analytical sensitivity and specificity.Library Prep Kit Selector Library Prep Kit Selector
Determine the best kit for your needs based on project type, starting material, and method or application.
Focused power to sequence targeted regions or 1 human exome per run.NextSeq 550 System
Flexible power to sequence up to 9 human exomes per run.HiSeq 4000 System
Production power to sequence up to 96 human exomes per run.
Scalable throughput and flexibility for virtually any genome, sequencing method, and scale of project.Platform Comparison Tool
Compare sequencing platforms and identify the best system for your lab and applications.Sequencing Reagents
Find kits that include sequencing reagents, flow cells, and/or buffers tailored to each Illumina sequencing system.
Performs targeted resequencing using fast and accurate Isaac algorithms for alignment and variant calling.BaseSpace Variant Interpreter
Leverages leading annotation databases and a powerful filtering interface for rapid identification of disease-associated variants.BaseSpace Integrative Genomics Viewer App
Associates single gene or list of genes with annotation data for pathways, diseases, tissues, and small molecules.
The Illumina genomics computing environment for NGS data analysis and management.BaseSpace Correlation Engine
A growing library of curated genomic data to support researchers in identifying disease mechanisms, drug targets, and biomarkers.Illumina DRAGEN Bio-IT Platform
The Illumina DRAGEN (Dynamic Read Analysis for GENomics) Bio-IT Platform provides ultra-rapid secondary analysis of NGS data.
This method provides useful information about coding mutations associated with tumor progression. By sequencing less than 2% of the genome, it is possible to sequence to higher depth more economically. Learn more about cancer exome sequencing.
Whole-exome sequencing of individuals or trios is a common approach to finding causal variants in cases of rare, complex, or Mendelian disorders. Learn more about causal variant discovery.
Exome sequencing is increasingly being applied in translational and clinical settings to understand the role of genetics in human disease. Learn more about translational research.
*Data calculations on file. Illumina, Inc., 2015